Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
Phase 2
Terminated
- Conditions
- Hematological MalignanciesLeukemiaMyelodysplastic SyndromeLymphoma
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2020-09-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 13
- Registration Number
- NCT00506948
- Locations
- ๐บ๐ธ
UT MD Anderson Cancer Center, Houston, Texas, United States
Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer
Phase 2
Completed
- Conditions
- Bladder Cancer
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT00506155
- Locations
- ๐บ๐ธ
UT MD Anderson Cancer Center, Houston, Texas, United States
Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma
Phase 2
Terminated
- Conditions
- Lymphoma
- Interventions
- Drug: Campath-1HDrug: G-CSFDrug: GM-CSFDrug: BCNUDrug: Stem Cell TransplantDrug: Preparative Regimen for Allogenic Stem Cell TransplantationDrug: CytarabineDrug: EtoposideDrug: MelphalanDrug: CampathDrug: FludarabineDrug: CyclophosphamideRadiation: Low dose total body irradiation
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2011-11-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT00505921
- Locations
- ๐บ๐ธ
UT MD Anderson Cancer Center, Houston, Texas, United States
Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
Phase 2
Completed
- Conditions
- Disorder Related to Bone Marrow TransplantationLymphoma
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT00506129
- Locations
- ๐บ๐ธ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Etiology of Multiple Myeloma: A Case-Control Study
- Conditions
- Multiple Myeloma
- Interventions
- Behavioral: Questionnaire
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2020-01-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 140
- Registration Number
- NCT00505999
- Locations
- ๐บ๐ธ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Erwinase Study in Patients With Acute Lymphoblastic Leukemia
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2014-09-11
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT00506597
- Locations
- ๐บ๐ธ
UT MD Anderson Cancer Center, Houston, Texas, United States
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2020-11-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00506779
- Locations
- ๐บ๐ธ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
FM 140 vs FM100 Study in Patients With Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2014-10-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 52
- Registration Number
- NCT00505895
- Locations
- ๐บ๐ธ
UT MD . Anderson Cancer Center, Houston, Texas, United States
Biochemotherapy With Temozolomide for Metastatic Melanoma
Phase 2
Terminated
- Conditions
- Melanoma
- Interventions
- First Posted Date
- 2007-07-23
- Last Posted Date
- 2020-09-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00505635
- Locations
- ๐บ๐ธ
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
Mifepristone for Patients With Endometrial Cancer and LGESS
- First Posted Date
- 2007-07-23
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 13
- Registration Number
- NCT00505739
- Locations
- ๐บ๐ธ
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath